IDH2 and astrocytoma (excluding glioblastoma): In the primary group, composed of IDH-mutated tumors, the World Health Organization (WHO) 2021 classification recognizes oligodendroglioma (presenting 1p19q codeletion) and astrocytoma (without 1p19q codeletion) (4).